Novel Compounds as 5-HT2A Receptor Modulators for Treating Psychiatric and Neurological Disorders.
ACS Med Chem Lett March 13, 2025 DOI: 10.1021/acsmedchemlett.5c00093 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Serotonin |
| Key points | Proposes that novel 5-HT2A receptor modulators may provide new therapeutic options for psychiatric and neurological disorders. |
Abstract
Novel Compounds as 5-HT2A Receptor Modulators for Treating Psychiatric and Neurological Disorders.